Soluble receptor for advanced glycation end products inhibits disease progression in autosomal dominant polycystic kidney disease by down-regulating cell proliferation

FASEB Journal

Volumn 29, Issue 8, 2015, Pages 3506-3514

  Lee, Eun Ji ^a   Park, Eun Young ^a   Mun, HyoWon ^a   Chang, EunSun ^a   Ko, Je Yeong ^a   Kim, Do Yeon ^a   Park, Jong Hoon ^a  

^a Sookmyung Women's University   (South Korea)

Author keywords

ADPKD; MAPK; SRAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; COMPLEMENTARY DNA; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN S 100; RNA; SHORT HAIRPIN RNA; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

ADENOVIRIDAE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CELL PROLIFERATION; CLONE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; LIVER TOXICITY; MOUSE; NONHUMAN; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RODENT MODEL; TOXICITY TESTING; WESTERN BLOTTING; WST-8 ASSAY; ANIMAL; CELL LINE; CHRONIC KIDNEY FAILURE; DOWN REGULATION; FIBROSIS; INFLAMMATION; KIDNEY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ADENOVIRIDAE; MUS;

ANIMALS; CELL LINE; CELL PROLIFERATION; DISEASE PROGRESSION; DOWN-REGULATION; FIBROSIS; HUMANS; INFLAMMATION; KIDNEY; KIDNEY FAILURE, CHRONIC; MICE; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; RECEPTORS, IMMUNOLOGIC;

EID: 84940434870     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.15-272302     Document Type: Article

References (29)

1. Ramasamy, R., and Yan., S. F., and Schmidt, A. M. (2012) The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes. Vascul. Pharmacol. 57, 160-167
2. Schmidt, A. M., and Yan., S. D., Yan, S. F., and Stern, D. M. (2000) The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta 1498, 99-111
3. Sparvero, L. J., Asafu-Adjei, D., Kang, R., Tang, D., Amin, N., Im, J., Rutledge, R., Lin, B., Amoscato, A. A., Zeh, H. J., and Lotze, M. T. (2009) RAGE (receptor for advanced glycation endproducts), RAGE ligands, and their roleincancer and inflammation. J. Transl. Med. 7, 17
4. Hudson, B. I., and Carter., A. M., Harja, E., Kalea, A. Z., Arriero, M., Yang, H., and Grant., P. J., and Schmidt, A. M. (2008) Identification, classification, and expression of RAGE gene splice variants. FASEB J. 22, 1572-1580
5. Huttunen, H. J., Kuja-Panula, J., Sorci, G., and Agneletti., A. L., Donato, R., and Rauvala, H. (2000) Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J. Biol. Chem. 275, 40096-40105
6. Zhu, P., Xie, L., Ding, H. S., Gong, Q., Yang, J., and Yang, L. (2013) High mobility group box 1 and kidney diseases (Review). [Review] Int. J. Mol. Med. 31, 763-768
7. Lin, L., Zhong, K., Sun, Z., Wu, G., and Ding, G. (2012) Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma. J. Cancer Res. Clin. Oncol. 138, 11-22
8. Bohlender, J.M., Franke, S., Stein, G., and Wolf, G. (2005) Advanced glycation end products and the kidney. Am. J. Physiol. Renal Physiol. 289, F645-F659
9. Chang, M. Y., and Ong, A. C. (2008) Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and treatment. Nephron, Physiol. 108, 1-7
10. Harris, P.C., and Torres, V.E. (2009) Polycystic kidney disease. Annu. Rev. Med. 60, 321-337
11. Nagao, S., Kugita, M., Yoshihara, D., and Yamaguchi, T. (2012) Animal models for human polycystic kidney disease. Exp. Anim. 61, 477-488
12. Ko, J. Y., and Park, J. H. (2013) Mouse models of polycystic kidney disease induced by defects of ciliary proteins. BMB Rrep. 46, 73-79
13. Raphael, K. L., and Strait., K. A., Stricklett, P.K., Miller, R. L., Nelson, R. D., Piontek, K. B., Germino, G. G., and Kohan, D. E. (2009) Inactivation of Pkd1 in principal cells causes a more severe cystic kidney disease than in intercalated cells. Kidney Int. 75, 626-633
14. Park, E. Y., and Kim., B. H., Lee, E. J., Chang, E., Kim, D. W., Choi, S. Y., and Park, J. H. (2014) Targeting of receptor for advanced glycation end products suppresses cyst growth in polycystic kidney disease. J. Biol. Chem. 289, 9254-9262
15. Park, E. Y., and Seo., M. J., and Park, J. H. (2010) Effects of specific genes activating RAGE on polycystic kidney disease. Am. J. Nephrol. 32, 169-178
16. Lee, E. J., and Song., S. A., Mun, H. W., Yoo, K. H., Choi, S. Y., Park, E. Y., and Park, J. H. (2014) Blockade of interleukin-8 receptor signalling inhibits cyst development in vitro, via suppression of cell proliferation in autosomal polycystic kidney disease. Nephrology (Carlton) 19, 471-478
17. Li, X., Magenheimer, B.S., Xia, S., Johnson, T., Wallace, D.P., and Calvet., J. P., and Li, R. (2008) A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease. Nat. Med. 14, 863-868
18. Ta, M. H., Harris, D.C., and Rangan, G. K. (2013) Role of interstitial inflammation in the pathogenesis of polycystic kidney disease. Nephrology (Carlton) 18, 317-330
19. Nakamura, T., Kawagoe, Y., Ueda, Y., Yamada, S., and Koide, H. (2011) Hemoperfusion treatment in a septic shock patient with autosomal dominant polycystic kidney disease and increased HMGB1 protein levels. Blood Purif. 32, 139-142
20. Nakamura, T., Sato, E., Fujiwara, N., Kawagoe, Y., Yamada, S., Ueda, Y., and Koide, H. (2012) Changes in urinary albumin excretion, inflammatory and oxidative stress markers in ADPKD patients with hypertension. Am. J. Med. Sci. 343, 46-51
21. Norman, J. (2011) Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD). Biochim. Biophys. Acta 1812, 1327-1336
22. LaRiviere, W. B., and Irazabal., M. V., and Torres, V. E. (2015) Novel therapeutic approaches to autosomal dominant polycystic kidney disease. Transl. Res. 165, 488-498
23. Rossetti, S., Chauveau, D., Kubly, V., Slezak, J.M., Saggar-Malik, A.K., Pei, Y., and Ong., A. C., Stewart, F., Watson, M. L., Bergstralh, E. J., Winearls, C. G., Torres, V. E., and Harris, P. C. (2003) Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet 361, 2196-2201
24. Shillingford, J. M., and Murcia., N. S., Larson, C. H., Low, S. H., Hedgepeth, R., Brown, N., and Flask., C. A., Novick, A. C., Goldfarb, D. A., Kramer-Zucker, A., Walz, G., and Piontek., K. B., Germino, G. G., and Weimbs, T. (2006) The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in poly-cystic kidney disease. Proc. Natl. Acad. Sci. USA 103, 5466-5471
25. Shillingford, J. M., and Piontek., K. B., Germino, G. G., and Weimbs, T. (2010) Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1. J. Am. Soc. Nephrol. 21, 489-497
26. Serra, A. L., Poster, D., Kistler, A. D., Krauer, F., Raina, S., Young, J., Rentsch, K. M., Spanaus, K. S., Senn, O., Kristanto, P., Scheffel, H., Weishaupt, D., and Wüthrich, R. P. (2010) Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N. Engl. J. Med. 363, 820-829
27. Novalic, Z., van der Wal, A. M., Leonhard, W. N., Koehl, G., Breuning, M. H., Geissler, E. K., de Heer, E., and Peters, D. J. (2012) Dose-dependent effects of sirolimus on mTOR signaling and poly-cystic kidney disease. J. Am. Soc. Nephrol. 23, 842-853
28. Yamaguchi, T., and Reif., G. A., Calvet, J. P., and Wallace, D. P. (2010) Sorafenib inhibits cAMP-dependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cells. Am. J. Physiol. Renal Physiol. 299, F944-F951
29. Neeper, M., and Schmidt., A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D., and Shaw, A. (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267, 14998-15004